Democratising and accelerating analysis of genetic data

In addition to drastically cutting the time taken to analyse genetic data, Omecu intends to bring its benefits to a much wider audience.

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

In addition to drastically cutting the time taken to analyse genetic data, Omecu intends to bring its benefits to a much wider audience.

University of Edinburgh spinout Omecu recently emerged from stealth and revealed its development of a powerful computational platform that simplifies and accelerates the analysis of genetic and epidemiologic datasets. The company claims that its technology can slash the time spent by researchers preparing and analysing this genetic data from days to seconds. It also aims to make this type of analysis accessible to researchers and clinicians who lack the technical skills previously needed to conduct it. While the platform is yet to be made commercially available, Omecu’s founders are planning to launch the product before the end of the year.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Danny Sullivan

Danny has worked in technology communications for more than 20 years, and has been writing about developments the longevity sector since 2019. With a keen interest in the transfer of technology to market, he focuses primarily on the companies working on cutting-edge solutions to aging and age-related diseases.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Evommune bets $30m upfront on a new autoimmune drug

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE